NFKB1 and breast carcinoma: TLR3 activation in breast cancer cells can also promote tumor growth and metastasis by triggering inflammation, angiogenesis, and immune suppression through pathways such as NF-κB and MAPK, by promoting the expression of pro-inflammatory cytokines, angiogenic factors, and regulatory cytokines (59).